Menu
GeneBe

SCGB1A1

secretoglobin family 1A member 1, the group of Secretoglobins

Basic information

Region (hg38): 11:62405102-62423195

Previous symbols: [ "UGB" ]

Links

ENSG00000149021NCBI:7356OMIM:192020HGNC:12523Uniprot:P11684AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SCGB1A1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SCGB1A1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
2
missense
3
clinvar
1
clinvar
4
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 3 2 1

Variants in SCGB1A1

This is a list of pathogenic ClinVar variants found in the SCGB1A1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-62419058-G-G Inherited susceptibility to asthma Uncertain significance (Jul 01, 2002)12253
11-62419070-G-A Chronic obstructive pulmonary disease association (Feb 03, 2021)1027621
11-62422221-C-T not specified Uncertain significance (Jan 04, 2024)3158401
11-62422239-C-T not specified Uncertain significance (Dec 27, 2023)3158402
11-62422240-G-A Likely benign (Dec 13, 2017)728710
11-62422264-C-T Benign (Jan 19, 2018)791050
11-62422302-T-C not specified Uncertain significance (May 16, 2024)3316459
11-62422407-T-C not specified Likely benign (Jan 03, 2024)3158399
11-62423081-T-C not specified Uncertain significance (Dec 30, 2023)3158400

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SCGB1A1protein_codingprotein_codingENST00000278282 318093
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0007990.342124089011240900.00000403
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1494851.00.9410.00000265596
Missense in Polyphen1312.6291.0293148
Synonymous-0.5212219.11.150.00000102176
Loss of Function-0.54342.991.341.26e-738

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000008920.00000892
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds phosphatidylcholine, phosphatidylinositol, polychlorinated biphenyls (PCB) and weakly progesterone, potent inhibitor of phospholipase A2.;
Pathway
Prostaglandin Synthesis and Regulation;FOXA1 transcription factor network (Consensus)

Recessive Scores

pRec
0.258

Intolerance Scores

loftool
0.686
rvis_EVS
0.06
rvis_percentile_EVS
58

Haploinsufficiency Scores

pHI
0.0730
hipred
N
hipred_score
0.310
ghis
0.435

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.733

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Scgb1a1
Phenotype
immune system phenotype; renal/urinary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; neoplasm; respiratory system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;signal transduction;female pregnancy;embryo implantation;response to xenobiotic stimulus;response to ozone;response to lipopolysaccharide;negative regulation of interferon-gamma production;negative regulation of interleukin-13 production;negative regulation of interleukin-4 production;negative regulation of interleukin-5 production;response to silicon dioxide;response to cytokine;negative regulation of T cell proliferation;negative regulation of catalytic activity;regulation of mRNA stability;regulation of inflammatory response;response to glucocorticoid;response to fibroblast growth factor
Cellular component
extracellular space;nuclear envelope;cytoplasm;rough endoplasmic reticulum;secretory granule;extracellular exosome
Molecular function
protein binding;phospholipase A2 inhibitor activity;polychlorinated biphenyl binding